AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
As a scientific organization focused on preventing and curing all cancers, the American Association for Cancer Research (AACR) embraces...
This month, the editors of the AACR’s journals have chosen to highlight an analysis of birth characteristics and risk...
AACR Virtual Annual Meeting II featured more than 20 minisymposia sessions during the three-day conference. One such minisymposium focused on Infection and...
Cancer is often described as a disease of old age. However, certain cancers have become increasingly prevalent among younger populations...
Pediatric cancer, while rare, is the leading cause of death by disease among children past infancy in the developed world. The World Health Organization notes...
“It’s going to be a vibrant session,” said session moderator Nada Jabado, MD, PhD. With these words, the first of two sessions featuring the...
The second day of the AACR Virtual Annual Meeting II began with a clinical trials plenary session. Two of the session’s presentations, which focused on immunotherapy clinical...
Following the resounding success of the First Virtual Annual Meeting with more than 61,000 attendees in April, the AACR...
The Opening Ceremony of the American Association for Cancer Research (AACR) Virtual Annual Meeting II provided a stark reminder that...
This year alone, an estimated 1.8 million people will hear their doctor say they have cancer. The individual impact...